These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 25140302)

  • 1. The motile breast cancer phenotype roles of proteoglycans/glycosaminoglycans.
    Nikitovic D; Kouvidi K; Voudouri K; Berdiaki A; Karousou E; Passi A; Tzanakakis GN
    Biomed Res Int; 2014; 2014():124321. PubMed ID: 25140302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the coordinated actions of estrogen receptors with epidermal growth factor receptor and insulin-like growth factor receptor in the expression of cell surface heparan sulfate proteoglycans and cell motility in breast cancer cells.
    Tsonis AI; Afratis N; Gialeli C; Ellina MI; Piperigkou Z; Skandalis SS; Theocharis AD; Tzanakakis GN; Karamanos NK
    FEBS J; 2013 May; 280(10):2248-59. PubMed ID: 23374155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of Proteoglycans and Glycosaminoglycans in Cancer Development and Progression.
    Wei J; Hu M; Huang K; Lin S; Du H
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro effects of genistein on the synthesis and distribution of glycosaminoglycans/proteoglycans by estrogen receptor-positive and -negative human breast cancer epithelial cells.
    Mitropoulou TN; Tzanakakis GN; Nikitovic D; Tsatsakis A; Karamanos NK
    Anticancer Res; 2002; 22(5):2841-6. PubMed ID: 12530007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteoglycan serglycin promotes non-small cell lung cancer cell migration through the interaction of its glycosaminoglycans with CD44.
    Guo JY; Chiu CH; Wang MJ; Li FA; Chen JY
    J Biomed Sci; 2020 Jan; 27(1):2. PubMed ID: 31898491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chondroitin sulfates play a major role in breast cancer metastasis: a role for CSPG4 and CHST11 gene expression in forming surface P-selectin ligands in aggressive breast cancer cells.
    Cooney CA; Jousheghany F; Yao-Borengasser A; Phanavanh B; Gomes T; Kieber-Emmons AM; Siegel ER; Suva LJ; Ferrone S; Kieber-Emmons T; Monzavi-Karbassi B
    Breast Cancer Res; 2011 Jun; 13(3):R58. PubMed ID: 21658254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-talk between estradiol receptor and EGFR/IGF-IR signaling pathways in estrogen-responsive breast cancers: focus on the role and impact of proteoglycans.
    Skandalis SS; Afratis N; Smirlaki G; Nikitovic D; Theocharis AD; Tzanakakis GN; Karamanos NK
    Matrix Biol; 2014 Apr; 35():182-93. PubMed ID: 24063949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NRF1 motif sequence-enriched genes involved in ER/PR -ve HER2 +ve breast cancer signaling pathways.
    Ramos J; Das J; Felty Q; Yoo C; Poppiti R; Murrell D; Foster PJ; Roy D
    Breast Cancer Res Treat; 2018 Nov; 172(2):469-485. PubMed ID: 30128822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into the key roles of proteoglycans in breast cancer biology and translational medicine.
    Theocharis AD; Skandalis SS; Neill T; Multhaupt HA; Hubo M; Frey H; Gopal S; Gomes A; Afratis N; Lim HC; Couchman JR; Filmus J; Sanderson RD; Schaefer L; Iozzo RV; Karamanos NK
    Biochim Biophys Acta; 2015 Apr; 1855(2):276-300. PubMed ID: 25829250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into targeting colon cancer cell fate at the level of proteoglycans / glycosaminoglycans.
    Nikitovic D; Chatzinikolaou G; Tsiaoussis J; Tsatsakis A; Karamanos NK; Tzanakakis GN
    Curr Med Chem; 2012; 19(25):4247-58. PubMed ID: 22709001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix glycosaminoglycans in the growth phase of fibroblasts: more of the story in wound healing.
    Kosir MA; Quinn CC; Wang W; Tromp G
    J Surg Res; 2000 Jul; 92(1):45-52. PubMed ID: 10864481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural Insights Into How Proteoglycans Determine Chemokine-CXCR1/CXCR2 Interactions: Progress and Challenges.
    Rajarathnam K; Desai UR
    Front Immunol; 2020; 11():660. PubMed ID: 32391006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miRNAs: Critical mediators of breast cancer metastatic programming.
    Nair MG; Somashekaraiah VM; Ramamurthy V; Prabhu JS; Sridhar TS
    Exp Cell Res; 2021 Apr; 401(1):112518. PubMed ID: 33607102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-191, an estrogen-responsive microRNA, functions as an oncogenic regulator in human breast cancer.
    Nagpal N; Ahmad HM; Molparia B; Kulshreshtha R
    Carcinogenesis; 2013 Aug; 34(8):1889-99. PubMed ID: 23542418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serglycin promotes breast cancer cell aggressiveness: Induction of epithelial to mesenchymal transition, proteolytic activity and IL-8 signaling.
    Bouris P; Manou D; Sopaki-Valalaki A; Kolokotroni A; Moustakas A; Kapoor A; Iozzo RV; Karamanos NK; Theocharis AD
    Matrix Biol; 2018 Dec; 74():35-51. PubMed ID: 29842969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteoglycans and their roles in brain cancer.
    Wade A; Robinson AE; Engler JR; Petritsch C; James CD; Phillips JJ
    FEBS J; 2013 May; 280(10):2399-417. PubMed ID: 23281850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteoglycans as miscommunication biomarkers for cancer diagnosis.
    Xu L; Tang L; Zhang L
    Prog Mol Biol Transl Sci; 2019; 162():59-92. PubMed ID: 30905465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTTG1 oncogene promotes tumor malignancy via epithelial to mesenchymal transition and expansion of cancer stem cell population.
    Yoon CH; Kim MJ; Lee H; Kim RK; Lim EJ; Yoo KC; Lee GH; Cui YH; Oh YS; Gye MC; Lee YY; Park IC; An S; Hwang SG; Park MJ; Suh Y; Lee SJ
    J Biol Chem; 2012 Jun; 287(23):19516-27. PubMed ID: 22511756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting.
    Theocharis AD; Skandalis SS; Tzanakakis GN; Karamanos NK
    FEBS J; 2010 Oct; 277(19):3904-23. PubMed ID: 20840587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteoglycans in cancer biology, tumour microenvironment and angiogenesis.
    Iozzo RV; Sanderson RD
    J Cell Mol Med; 2011 May; 15(5):1013-31. PubMed ID: 21155971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.